Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)

This grant opportunity, PAR-25-247, from the NIH aims to fund institutional training programs focused on advancing translational research in Alzheimer's Disease (AD) and AD-Related Dementias (ADRD). Clinical trials are not allowed under this funding opportunity, which falls under CFDA 93.866.